These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23419703)

  • 1. Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
    Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
    Blood Cells Mol Dis; 2013 Jun; 51(1):48-55. PubMed ID: 23419703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR2 may influence the behavior of the malignant clone in B-CLL.
    Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
    Blood Cells Mol Dis; 2012 Jun; 49(1):32-40. PubMed ID: 22521894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
    Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
    Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
    Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
    Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique feature of Toll/IL-1 receptor domain-containing adaptor protein is partially responsible for lipopolysaccharide insensitivity in zebrafish with a highly conserved function of MyD88.
    Liu Y; Li M; Fan S; Lin Y; Lin B; Luo F; Zhang C; Chen S; Li Y; Xu A
    J Immunol; 2010 Sep; 185(6):3391-400. PubMed ID: 20702732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes.
    Antosz H; Sajewicz J; Marzec-Kotarska B; Kocki J; Dmoszyńska A
    Folia Histochem Cytobiol; 2009; 47(4):593-8. PubMed ID: 20430725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of interactions between TLR2, MyD88 and TIRAP by bioluminescence resonance energy transfer is hampered by artefacts of protein overexpression.
    Sampaio NG; Kocan M; Schofield L; Pfleger KDG; Eriksson EM
    PLoS One; 2018; 13(8):e0202408. PubMed ID: 30138457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
    Toshchakov V; Jones BW; Perera PY; Thomas K; Cody MJ; Zhang S; Williams BR; Major J; Hamilton TA; Fenton MJ; Vogel SN
    Nat Immunol; 2002 Apr; 3(4):392-8. PubMed ID: 11896392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIRAP: an adapter molecule in the Toll signaling pathway.
    Horng T; Barton GM; Medzhitov R
    Nat Immunol; 2001 Sep; 2(9):835-41. PubMed ID: 11526399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis.
    Sacre SM; Andreakos E; Kiriakidis S; Amjadi P; Lundberg A; Giddins G; Feldmann M; Brennan F; Foxwell BM
    Am J Pathol; 2007 Feb; 170(2):518-25. PubMed ID: 17255320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
    Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous Expression and Assembly of Human TLR Signaling Components in
    Coronas-Serna JM; Del Val E; Kagan JC; Molina M; Cid VJ
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
    Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88.
    Ohnishi H; Tochio H; Kato Z; Kawamoto N; Kimura T; Kubota K; Yamamoto T; Funasaka T; Nakano H; Wong RW; Shirakawa M; Kondo N
    PLoS One; 2012; 7(6):e38423. PubMed ID: 22685567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6, IL-10, c-Jun and STAT3 expression in B-CLL.
    Antosz H; Wojciechowska K; Sajewicz J; Choroszyńska D; Marzec-Kotarska B; Osiak M; Pająk N; Tomczak W; Jargiełło-Baszak M; Baszak J
    Blood Cells Mol Dis; 2015 Mar; 54(3):258-65. PubMed ID: 25477266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MyD88 adaptor-like D96N is a naturally occurring loss-of-function variant of TIRAP.
    George J; Kubarenko AV; Rautanen A; Mills TC; Colak E; Kempf T; Hill AV; Nieters A; Weber AN
    J Immunol; 2010 Mar; 184(6):3025-32. PubMed ID: 20164415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
    Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
    Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.